Sanofi says on track to regain solid position in cancer drugs


PARIS (Reuters) – Sanofi believes it can make a comeback and re-establish a leading position in the competitive cancer drug market on the back of its immunotherapy drugs and efforts in new areas such as molecular oncology.

FILE PHOTO: French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo

“We missed the immunology wagon in recent years but we are committed to catching up and we have a significant number of assets,” Jorge Insuasty, Sanofi’s global head of development, told journalists on…



Read More Here

Be the first to comment on "Sanofi says on track to regain solid position in cancer drugs"

Leave a comment

Your email address will not be published.


*